Trump Makes New Rules for Some Drugs and Fights Others
Introduction
On April 18, 2025, President Trump signed an order to make psychedelic drugs easier to approve. In December 2024, he ordered to change the rules for medical marijuana. At the same time, his government is fighting fentanyl very hard and cutting money for programs that help people with drug problems.
Main Body
The new rules let medical marijuana move to a less strict category. This means scientists can study it more easily. In Colorado, state-licensed growers can now give cannabis to researchers. This helps them study if it can help with anxiety or pain. Also, the government gave special vouchers to speed up approval for psychedelic drugs. One company's stock price went up a lot. But the government also did other things. It stopped giving money to programs that give clean needles or naloxone to stop overdoses. It cut many jobs at a health agency. It called fentanyl a weapon of mass destruction. This lets the military help stop it. It made new laws with long prison sentences for having fentanyl. It also attacked drug boats in the sea. Some people say the new rules are good progress. Others say the government is making the drug war worse. Some say the government uses fentanyl as a reason to use the military. Others say the government is too easy with marijuana and psychedelics. The government also plans to cut money for Medicaid and food help. This makes it harder for people to recover. No president since Nixon has made drugs easier to get like this. But also no president has used the military so much for drugs. The future is not clear. If the rules stay, more research can happen. But the changes only cover drugs that people like. It is not a big change for all drugs.
Conclusion
So, the Trump government has two different drug policies. It makes marijuana and psychedelics easier to use for medicine. But it fights fentanyl very hard and cuts help for people with addiction. This creates a confusing situation. What happens next depends on new rules and public support.